Skip to main content

and
Your search also matched 5 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Tumor infiltrating lymphocytes as adjuvant treatment in stage III melanoma patients with only one invaded lymph node after complete resection: results from a multicentre, randomized clinical phase III trial

Include preview-only content
  1. Article

    Open Access

    Phase I/II clinical trial of adoptive cell transfer of sorted specific T cells for metastatic melanoma patients

    Adoptive cell transfer (ACT) of tumor-specific T lymphocytes represents a relevant therapeutic strategy to treat metastatic melanoma patients. Ideal T-cells should combine tumor specificity and reactivity with...

    Brigitte Dréno, Amir Khammari, Agnès Fortun in Cancer Immunology, Immunotherapy (2021)

  2. Article

    Long-term follow-up of patients treated by adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma

    The first analysis of our clinical trial on interest of using tumor-infiltrating lymphocytes (TIL) as adjuvant therapy for stage III (regional lymph nodes) melanoma was published in 2002 [5]. The aim of this pape...

    Amir Khammari, Jean-Michel Nguyen in Cancer Immunology, Immunotherapy (2007)

  3. Article

    Randomized trial of adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma

    The aim of this study was to demonstrate the interest of using tumor-infiltrating lymphocytes (TIL) as adjuvant therapy for stage III (regional lymph nodes) melanoma. After lymph node excision, patients witho...

    Brigitte Dréno, Jean-Michel Nguyen, Amir Khammari in Cancer Immunology, Immunotherapy (2002)